Key facts
- This page summarizes Michael P. Samar's Form 4 filing for ASSEMBLY BIOSCIENCES, INC. (ASMB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Jul 2022, 17:00.
Michael P. Samar - 25 Jul 2022 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ASMB
- Reported as of
- 25 Jul 2022
- Net transaction value
- -$4,479
- SEC form
- 4
- Accepted by SEC
- 26 Jul 2022, 17:00:11 UTC
- Prior SEC filing
- 27 Jun 2022
- Next SEC filing
- 26 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ John O. Gunderson, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael P. Samar filed Form 4 for ASSEMBLY BIOSCIENCES, INC. (ASMB) on 26 Jul 2022.
Change
- Previous filing in this sequence was filed on 27 Jun 2022.
- Current net transaction value: -$4,479.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASMB
transaction
Common Stock
Sale
- Transaction value
- $4,479
- Shares
- -2,020
- Change %
- -2.5%
- Price
- $2.22
- Shares after
- 77,228
- Date
- 25 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.14 to $2.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Footnote F3
Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on May 13, 2022.